ISIS. Strategic Collaboration & License Agreement between Isis Pharmaceuticals, Inc. (“Isis”), and Alnylam, dated March 11, 2004, as supplemented or amended by letter agreements dated March 9, 2004 (as amended by letter agreement dated October 28, 2005), March 11, 2004, June 10, 2005 and two letter agreements dated January 31, 2008 (as amended, “Isis Agreement”)
Appears in 1 contract
Sources: License and Collaboration Agreement (Alnylam Pharmaceuticals, Inc.)
ISIS. Strategic Collaboration & License Agreement between Isis Pharmaceuticals, Inc. (“Isis”), and Alnylam, dated March 11, 2004, as supplemented or amended by letter agreements dated March 9, 2004 (as amended by letter agreement dated October 28, 2005), March 11, 2004, and June 10, 2005 and two letter agreements dated January 31, 2008 (as amended, “Isis Agreement”) Limitations on License Grant (Section 5.1)
Appears in 1 contract
Sources: License and Collaboration Agreement (Arrowhead Research Corp)